Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Aptevo Therapeutics Inc. (APVO)

  • Technical Exchange News
  • March 20, 2024, 21:02 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Mustang Bio Inc (MBIO)

  • Technical Exchange News
  • March 20, 2024, 21:02 UTC
  • 38
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Aptevo Therapeutics Inc. (APVO)

  • Technical Exchange News
  • March 20, 2024, 21:02 UTC
  • 38
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Protagenic Therapeutics Inc. (PTIX)

  • Technical Exchange News
  • March 19, 2024, 18:57 UTC
  • 35
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Bio-Path Holdings Inc. (BPTH)

  • Technical Exchange News
  • March 19, 2024, 18:56 UTC
  • 36
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Protagenic Therapeutics Inc. (PTIX)

  • Technical Exchange News
  • March 19, 2024, 18:39 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Bio-Path Holdings Inc. (BPTH)

  • Technical Exchange News
  • March 19, 2024, 18:38 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Atreca Inc. (BCEL)

  • Technical Exchange News
  • March 19, 2024, 00:11 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Atreca, Inc. - Class A Common Stock. New value: Atreca, Inc. - Class A Common Stock.

Comment Full text

Atreca Inc. (BCEL)

  • Technical Exchange News
  • March 19, 2024, 00:11 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Atreca, Inc. - Class A Common Stock.

Comment Full text

Atreca Inc. (BCEL)

  • Technical Exchange News
  • March 19, 2024, 00:11 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Atreca, Inc. - Class A Common Stock.

Comment Full text
  • Previous
  • 1003
  • 1004
  • 1005
  • 1006
  • 1007
  • Next

Search

News categories

  • Technical Exchange News(14604)
  • Event(6229)
  • SEC News(385338)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235139)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin